CANCER RESEARCH CAREER ENHANCEMENT (CRCE) The Fred Hutch/University of Washington Cancer Consortium aims to be at the forefront of training the next generation of scientists and clinicians to best position them to lead efforts to eliminate cancer. Education and training has always been a core value and central to our mission, and we propose here to continue to emphasize and enhance our training mission and footprint.
The specific aims for CRCE are (1) to provide exceptional training and support for graduate students and postdoctoral and clinical fellows so that they will be poised to tackle a range of careers in cancer research; (2) to encourage young students to engage in and experience science and to provide exposure and opportunities for those from groups that are underrepresented minorities (URMs) in science; (3) to maximize the success of junior faculty through mentoring and support as they transition to independent scientists; and (4) to support the pipeline of educational and training opportunities of the Consortium. To support our training efforts, we host a large and comprehensive set of T32 grants (n=47), of which 32 have Consortium faculty as mentors, 17 are led by Consortium PIs, and 7 are from NCI. The eight T32s with the strongest cancer focus collectively support 39 trainees/year, and an additional 95 trainees are supported by T32s that include cancer research as a component. Some of these grants have been in continuous existence for more than 4 decades (e.g., Molecular & Cellular Biology, Medical Scientist Training Program, Medical Genetics, Hematology). The caliber of our trainees and their success is illustrated by current active awards of 1 K99 grant, 6 K01 or K22 grants, 10 F32 grants, 2 Jane Coffin Childs Fellowships, 4 Damon Runyon Cancer Research Awards, and 4 Susan G. Komen Fellowships. This Cancer Research Career Enhancement (CRCE) component will serve as a centralized resource that integrates and supports these efforts, encourages the continuum of training and mentoring, and supports continued innovation in our education pipeline.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853646
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515
Ranola, John Michael O; Pearlman, Rachel; Hampel, Heather et al. (2018) Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio. Fam Cancer :
Dai, James Y; Liang, C Jason; LeBlanc, Michael et al. (2018) Case-only approach to identifying markers predicting treatment effects on the relative risk scale. Biometrics 74:753-763
Huang, Yijian; Wang, Ching-Yun (2018) Cox regression with dependent error in covariates. Biometrics 74:118-126
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746

Showing the most recent 10 out of 1267 publications